Bioventix Balance Sheet

Financials in millions GBP. Fiscal year is July - June.

Millions GBP. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Cash & Equivalents	5.08	6	5.72	6.13	6.49
Cash & Short-Term Investments	5.08	6	5.72	6.13	6.49
Cash Growth	-15.33%	4.95%	-6.71%	-5.67%	-19.58%
Accounts Receivable	1.03	1.52	1.17	0.75	0.64
Other Receivables	0.03	0.03	0	0.01	0.01
Receivables	1.06	1.55	1.17	0.76	0.65
Inventory	0.69	0.62	0.57	0.46	0.33
Prepaid Expenses	5.18	4.66	4.64	4.46	3.98
Total Current Assets	12.03	12.83	12.1	11.81	11.45
Property, Plant & Equipment	0.4	0.48	0.58	0.69	0.84
Long-Term Investments	0.43	0.43	0.61	0.61	0.61
Total Assets	12.86	13.73	13.28	13.12	12.91
Accounts Payable	0.08	0.17	0.08	0.16	0.15
Accrued Expenses	0.4	0.4	0.41	0.39	0.32
Current Income Taxes Payable	0.84	1.15	0.71	0.71	0.54
Total Current Liabilities	1.31	1.73	1.2	1.25	1.01
Long-Term Deferred Tax Liabilities	-	-	0.02	0.04	0.08
Total Liabilities	1.31	1.73	1.22	1.3	1.09
Common Stock	0.26	0.26	0.26	0.26	0.26
Additional Paid-In Capital	1.54	1.47	1.47	1.33	1.33
Retained Earnings	9.75	10.27	10.33	10.23	10.23
Comprehensive Income & Other	0	0	0	0	0
Shareholders' Equity	11.55	12	12.06	11.82	11.82
Total Liabilities & Equity	12.86	13.73	13.28	13.12	12.91
Net Cash (Debt)	5.08	6	5.72	6.13	6.49
Net Cash Growth	-15.33%	4.95%	-6.71%	-5.67%	-19.58%
Net Cash Per Share	0.96	1.13	1.08	1.16	1.23
Filing Date Shares Outstanding	5.22	5.22	5.22	5.21	5.21
Total Common Shares Outstanding	5.22	5.22	5.22	5.21	5.21
Working Capital	10.72	11.1	10.9	10.56	10.44
Book Value Per Share	2.21	2.30	2.31	2.27	2.27
Tangible Book Value	11.55	12	12.06	11.82	11.82
Tangible Book Value Per Share	2.21	2.30	2.31	2.27	2.27
Machinery	0.95	0.96	0.94	0.93	1.08

Source: S&P Global Market Intelligence. Standard template. Financial Sources.